Table 1.
Participant characteristics at time of first oral HPV detection
| Participant characteristica | No. | % |
|---|---|---|
| Sex | ||
| Women (WIHS) | 274 | 46% |
| Men (MACS) | 320 | 54% |
| Infection typeb | ||
| Incident only | 189 | 32% |
| Any Prevalent (with or without incident) | 405 | 68% |
| Age (year) | ||
| <45 | 162 | 27% |
| 45–54 | 258 | 43% |
| ≥55 | 174 | 29% |
| Race/Ethnicity | ||
| White, non-Hispanic | 186 | 31% |
| Black, non-Hispanic | 328 | 55% |
| Hispanic (any race) | 80 | 14% |
| Study sitec | ||
| Baltimore, Maryland | 88 | 15% |
| Bronx, New York | 93 | 16% |
| Brooklyn, New York | 84 | 14% |
| Chicago, Illinois | 202 | 34% |
| Los Angeles, California | 24 | 4% |
| Pittsburgh, Pennsylvania | 103 | 17% |
| HIV status | ||
| Uninfected | 168 | 28% |
| Infected | 426 | 72% |
| AMONG HIV INFECTED | ||
| Current CD4+ T cell count (cells/µL) | ||
| ≥500 | 212 | 50% |
| <500 | 214 | 50% |
| Current HIV RNA viral load (copies/mL) | ||
| <200 | 286 | 68% |
| 200–19,999 | 78 | 19% |
| ≥20,000 | 57 | 14% |
| Current ART use | ||
| No | 83 | 20% |
| Yes | 343 | 81% |
a
All participant characteristics are from the time of oral HPV detection
b
Prevalent infection was defined as oral HPV detected at POPS enrollment. Incident infection was defined as newly detected oral HPV preceded by at least one HPV-negative oral rinse. Some participants had prevalent infection, followed by incident infection of another HPV type that was included in the analysis.
c
Baltimore, Los Angeles and Pittsburgh study sites enrolled men only (MACS). Bronx and Brooklyn study sites enrolled women only (WIHS). Chicago study site enrolled both men and women.